Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

NCT04358068 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

NIH

Sponsor class

Stopped Slow enrollment and lack of community enthusiasm

Conditions

COVID-19
SARS-CoV 2

Interventions

DRUG: Hydroxychloroquine (HCQ)
DRUG: Azithromycin (Azithro)
DRUG: Placebo for Hydroxychloroquine
DRUG: Placebo for Azithromycin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]